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Abstract Dairy products provide a package of essential
nutrients that is difficult to obtain in low-dairy or dairy-free
diets, and for many people it is not possible to achieve rec-
ommended daily calcium intakes with a dairy-free diet.
Despite the established benefits for bone health, some people
avoid dairy in their diet due to beliefs that dairy may be
detrimental to health, especially in those with weight man-
agement issues, lactose intolerance, osteoarthritis, rheuma-
toid arthritis, or trying to avoid cardiovascular disease. This
review provides information for health professionals to
enable them to help their patients make informed decisions
about consuming dairy products as part of a balanced diet.
Theremay be aweak association between dairy consumption
and a possible small weight reduction, with decreases in fat
mass and waist circumference and increases in lean body
mass. Lactose intolerant individuals may not need to com-
pletely eliminate dairy products from their diet, as both
yogurt and hard cheese are well tolerated. Among people
with arthritis, there is no evidence for a benefit to avoid dairy
consumption. Dairy products do not increase the risk of
cardiovascular disease, particularly if low fat. Intake of up to
three servings of dairy products per day appears to be safe
and may confer a favourable benefit with regard to bone
health.
Keywords Dairy products  Cardiovascular disease 
Osteoporosis  Arthritis  Weight management  Lactose
intolerance
Introduction
Dairy products have been an important part of the human
diet for some 8000 years and are part of the official
nutritional recommendations in many countries worldwide.
They provide a package of key nutrients that are difficult to
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obtain in diets with limited or no dairy products, such as
vegan or dairy restrictive diets. Indeed, dairy products are
rich in calcium, protein, potassium and phosphorus. They
contribute around 52–65 % of the dietary reference intake
(DRI) of calcium and 20–28 % of the protein requirement,
depending on the age of the consumer [1–5]. The contribu-
tion of dairy products to providing recommended calcium
intakes has largely driven the dietary recommendations for
dairy intake in most guidelines. Up to two-thirds of the
population’s calcium intake inWestern countries is supplied
by dairy products [6, 7], while at the same time dairy foods
represent only 9–12 % of the total energy consumption [8].
Much research is still ongoing into the health effects of
dairy product consumption. This article examines some
clinical evidence and provides information for health pro-
fessionals to enable them to help their patients make
informed decisions about consuming dairy products as part
of a balanced diet. In particular, the effect of dairy products
on bone health, obesity, arthritis and cardiovascular disease
are briefly discussed.
Methods
This commentary is based on a narrative literature review.
It focusses on the most robust available evidence where
possible, for example meta-analyses and prospective
studies, with the most recent publications consulted. Rel-
evant articles were identified through a systematic search,
from 1966 to 2013 in MEDLINE with the keywords «dairy
products», «bone» and «muscle». Only articles published
in English were considered. Following this extensive
search of the literature, a critical appraisal was obtained
through three face-to-face consensus experts meetings,
held during the second part of the year 2013 and the first
part of the year 2014. For the purposes of this article, dairy
products refer to animal milks and derived products,
excluding butter and vegetable-derived products like soy or
almond ‘milks’.
Dairy Products as a Source of Key Nutrients
Worldwide, many people fail to achieve an adequate
dietary calcium intake. The adequacy of dietary calcium
consumption varies geographically and reflects milk con-
sumption. Intakes of calcium are generally low across
Europe [9]; judged against the World Health Organization/
Food and Agriculture Organization of the United Nations
(WHO/FAO) adult recommend nutrient intake (RNI) of
1000 mg/d, mean calcium intakes of 16 European countries
were 687–1171 mg/day in men and 508–1047 mg/d in
women [9]. Other nations fall far short of RNIs; for
example, in Brazil 99 % of adults (19–60 years) consume
inadequate levels of calcium [10].
To meet the daily dietary calcium requirement, dairy
products, green vegetables and mineral waters are impor-
tant, easily available, sources of calcium. Indeed, dairy
products represent good dietary sources of calcium due to
their high calcium and nutrient contents, high absorptive
rate, availability and relatively low cost, which makes the
regular consumption of dairy products feasible. They pro-
vide more calcium, protein, magnesium, potassium, zinc
and phosphorus per calorie than any other typical food
found in the adult diet [11, 12]. Many dietary recommen-
dations include the consumption of 3 servings of dairy
products per day (for example, 1 glass of milk, 1 portion of
cheese, 1 yogurt)—an amount that provides most of the
DRI of calcium for the general population [13]. For
example, 250 mg of calcium may be obtained from a
200 ml glass of milk, a 125 g serving of yogurt or 35 g of
hard cheese (Table 1) [14].
There are non-dairy sources of calcium, such as mineral
water, kale and dark greens, dried beans and legumes, but it
is difficult to meet daily requirements with these. A variety
of calcium-fortified foods, such as orange juice and soy
juice, are now available and provide the same amount of
calcium as a single serving of dairy; the amounts have been
evaluated at 1.1 servings of fortified soy beverage, 0.6
servings of fortified orange juice, 1.2 servings of bony fish
or 2.2 servings of leafy greens [15]. However, these foods
do not provide the equivalent profile of other nutrients and
the amounts needed are unrealistic in some cases [16].
Using data from the National Health and Nutrition Exam-
ination Survey (NHANES), it has been determined that it is
impossible to meet calcium recommendations while
meeting other nutrient recommendations with a dairy-free
diet within the current US dietary pattern [17]. The nutri-
ents most at risk if dairy products are excluded are calcium,
potassium and magnesium. For women of 19–50 years of
age who do not consume dairy products, only 44 % of
calcium and 57 % of magnesium and potassium recom-
mendations are met [18].
Under normal dietary conditions, about 30–40 % of the
calcium contained in milk and cheese is absorbed in the gut
either through vitamin D-dependent transport across the
duodenum, facilitated diffusion or under the influence of
lactose in the distal small intestine via the paracellular
route [12]. In contrast, only 28–36 % of the calcium is
absorbed from fortified cereals, soy (if not dephytized) and
rice juice [19]. Calcium is found in green leafy vegeta-
bles in reasonable quantity (Table 2) [20]; however, a high
proportion of the calcium is made insoluble by the presence
of fibres, phytic acid and oxalic acid, which reduce the
bioavailability of calcium. For example, cooked spinach
contains 115 mg of calcium per serving but only 5 % of
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spinach calcium is absorbed, as spinach contains a high
proportion of oxalates and phytates, which bind calcium
and form insoluble salt compounds [20]. Thus, while
consumption of 1 cup of milk per day may be considered
feasible to provide 100 mg of absorbed calcium, the con-
sumption of 16 servings of spinach per day to provide the
same amount of bioavailable calcium may be considered
unpalatable (Table 2).
Dairy foods also contain protein, with a 200 ml glass of
milk also providing around 6–7 g of mostly casein and
whey proteins [21]. The casein phosphopeptides (CPP) and
lactose in dairy foods can facilitate intestinal calcium
absorption [6, 22]. For example, the enzymatic hydrolysis
of casein protein leads to the formation of CPP. These
molecular species have been shown to bind calcium and
therefore protect it against precipitation with anions such as
phosphates in the small intestine. The net result is an
increase of passive calcium absorption in the ileum [23].
Phosphorus (P) ions are also present in milk, generally
combined with proteins and peptides. At the kidney level,
increased inorganic phosphate intake leads to decreased
urinary calcium and increased calcium retention. During
growth and adulthood, the administration of calcium and
inorganic phosphate in a ratio close to that found in dairy
products leads to positive effects on bone health [24].
Calcium and inorganic phosphate interact at both the
intestinal and renal levels and impact on bone maintenance
and osteoporosis management. Interactions between cal-
cium, inorganic phosphate, protein and vitamin D reduce
bone resorption, attenuating age-related bone loss [24].
Dairy Foods or Calcium Supplements?
Increased awareness about the impact of nutrition on health
and the availability of dietary supplements in shops has
made them popular choices, with 43 % of Americans using
Table 1 Essential nutrient content per 100 g of selected dairy foods
Dairy food (food code) Calcium (mg) Potassium (mg) Phosphorus (mg) Magnesium (mg) Zinc (mg) Protein (g)
Milk, full-fat 3.7 % (01078) 119 151 93 13 0.38 3.3
Milk, skimmed (01151) 122 156 101 11 0.42 3.4
Yogurt, plain low-fat (01117)a 183 234 144 17 0.89 5.3
Yogurt, fruit low-fat (01122)a 169 216 133 16 0.82 4.9
Cheddar cheese (01009) 721 98 512 28 3.11 24.9
Cottage cheese, non-fat (01014) 86 137 190 11 0.47 10.3
Ice cream, vanilla (19095) 128 199 105 14 0.69 3.5
Source Compiled from U.S. Department of Agriculture, Agricultural Research Service. 2013. USDA National Nutrient Database for Standard
Reference, Release 26. Available from: Nutrient Data Laboratory Home Page: http://www.ars.usda.gov/ba/bhnrc/ndl [14]
a A higher content of calcium and protein may be found in American yogurts compared with those found in Europe, as milk powder is added to
thicken the consistency. In Europe, the calcium and protein contents of yogurts are similar to those of milk
Table 2 Comparison of the amount of absorbable calcium in calcium-rich foods
Food Standard serving
sizea (g)
Calcium content/
serving (mg)
Calcium absorbed/
serving (mg)
Servings needed to
equal 240 ml milk
Milk 240 300 96 1.0
Yogurt 240 300 96 1.0
Cheddar cheese 42 303 97 1.0
Tofu with calcium 126 258 80 1.2
Bok choy 85 79 43 2.3
Kale 85 61 30 3.2
Broccoli 71 35 21 4.5
Spinach 85 115 6 16.3
Red beans 172 41 10 9.7
White beans 110 113 25 3.9
Pinto beans 86 45 12 8.1
Rhubarb 120 174 10 9.5
Source Adapted from Weaver 1999 [20]
a 1 serving = 240 ml milk; 42 g (1.5 oz) cheese; 85 g green leafy vegetables
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calcium supplements [25]. The absorption of calcium from
commonly used supplements, such as calcium carbonate
and calcium citrate, is around 30–40 % and is optimized by
concurrent food intake and by taking divided doses with
protein-containing meals throughout the day [6]. However,
calcium supplements can interact with several medications:
the absorption of calcium from calcium carbonate is
reduced by proton pump inhibitors, while calcium sup-
plements may interact with antibiotics, thiazide diuretics,
digoxin and phenytoin. Furthermore, calcium supplements
do not contain the additional nutrients—including protein,
potassium and magnesium—provided by dairy foods.
Although studies have generally failed to demonstrate
that dairy calcium is better absorbed than calcium from
mineral salts, the availability for bonemineralisation appears
to be greater for dairy foods and the effects may be longer
lasting [11]. Consequently, head-to-head intervention trials
show bone-health benefits for dairy foods over calcium
supplements. In postmenopausal women, those randomised
to dairy (low-fat milk and yogurt products, fortified with
concentratedmilk protein) had greater improvements in arm,
pelvis, total spine and total-body bone mineral density
(BMD) than those receiving calcium supplements in one trial
[26, 27], though not at other sites in another trial [28]. In
another randomised trial, cheese was more beneficial than
calcium supplements for tibia cortical bone mass accrual in
children [22]. The authors suggested that this may be a result
of better absorption of dairy calcium, differences in the
distribution of intake over the day (small regular amounts of
dairy versus two large doses from the supplement) and dif-
ferences in protein or micronutrient intakes [22]. Greater
increases in insulin-like growth factor-I (IGF-I), which
favours bone formation, have also been reported for dairy
compared with calcium supplements [26].
Dairy sources of calcium are considered to be at least as
effective for bone health as calcium supplements, and
probably more so [11]. A consensus statement from the
Belgian Bone Club suggests that for the non-pharmaco-
logical management of osteoporosis, single-nutrient sup-
plements will frequently be inadequate and preference
should go to the use of complete supplements or complete
foods such as dairy products [29]. Calcium supplementa-
tion should only be targeted to those who do not get suf-
ficient calcium from their diet and who are at high risk for
osteoporosis and/or fracture [30].
Bone Health: Effect of Dairy Products
Consumption
Bone mineral mass is determined by the amount of bone
accumulated at the end of skeletal growth (peak bone mass)
and by the amount of bone lost subsequently. Building a
strong skeleton from foetal life to adulthood and main-
taining healthy bones through the menopause and ageing
are vital to minimize frailty in the elderly. After the age of
20 years, there is little change in bone mineral mass until
the menopause in women, when a rapid drop in oestrogen
leads to an increase in bone remodelling. Menopause is
associated with an average annual bone loss of 3–5 %
during the first few years and around 1 % thereafter [31]. In
men, bone loss is slower and more linear, but men also
develop osteoporosis with ageing. The risk of osteoporosis
significantly increases after 50 years of age.
There is growing evidence that the consequences of age-
related or postmenopausal bone loss on fracture risk
depend on the level of peak bone mass achieved during
childhood and adolescence, as well as on the rate of bone
loss [32]. Maximizing peak bone mass may be an important
contributor to fracture risk reduction in children as well as
in the elderly. While 60–80 % of the variance in peak bone
mass is explained by genetic factors, the remainder may be
amenable to interventions aimed at maximizing it [32, 33].
Such interventions include increasing physical activity and
decreasing exposure to risk factors such as cigarette
smoking and excessive alcohol intake, as well as opti-
mizing nutrition [21, 32]. Adequate dietary calcium and
protein intakes are essential to achieve optimal peak bone
mass during skeletal growth and to prevent bone loss in the
elderly [34].
Dairy Consumption for Bone Development
in Children
The importance of dietary calcium for bone growth is
evident even prior to birth. Diets rich in calcium and other
micronutrients (as supplied by dairy foods, green leafy
vegetables, fruits) given to pregnant women are associated
with increased skeletal growth and/or bone mass/density in
the offspring, with beneficial effects on bone size and BMD
apparent up to the ages of 6–9 years [35, 36]. This is
compatible with the hypothesis that dairy consumption by
pregnant women might promote bone health in the child.
During childhood, the available data indicate that dairy
products are important for growth and bone health [37]. In
growing children, long-term milk avoidance is associated
with smaller stature, lower bone mineral mass, and
increased fracture risk before puberty of around 2.7-fold
higher than a matched birth cohort [38, 39]. The largest
randomised controlled trial (RCT) with dairy products
found significantly higher gains in height, body weight,
bone mineral content (BMC) and BMD in school girls aged
10 years receiving milk on school days for 2 years com-
pared with the control group [40]. The beneficial effects of
calcium and dairy products on bone mineral mass during
growth in children are supported by meta-analyses of
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numerous clinical studies on milk-derived calcium phos-
phate supplementation and increased dietary dairy prod-
ucts, with a statistically and clinically higher gain of bone
mineral content in those with low basal calcium intake [41,
42]. This significant increase in bone mass following cal-
cium enrichment of the diet observed in pre-pubertal girls
and boys [43, 44] was maintained for 1–3 years after the
end of the trial [44, 45], suggesting a possible optimization
of peak bone mass when calcium supply is sufficient.
Increasing dairy product consumption in girls aged
10–12 years was found to be more beneficial for cortical
bone mass accrual than calcium supplementation in tablet
form for the same calcium intake (1000 mg/d) [22].
Besides mineral intake, a higher protein intake interacts
with physical activity to enhance bone mass acquisition
before the onset of puberty [3].
In summary, numerous observational studies and RCTs
have shown a favourable effect of dairy products on bone
health during childhood and adolescence. Conversely,
avoiding milk is linked to a lower BMC [22] and increased
fracture risk [22] in children.
Dairy Consumption for Osteoporosis Prevention
and Reduction of Fracture Risk in Adults
European guidance on osteoporosis incorporates nutritional
recommendations for bone health, including at least
1000 mg/d calcium and 800 IU/d vitamin D [30]. For
comparison, Recommended Dietary Allowance (RDA, mg/
d) for calcium is 1200 for postmenopausal women
according to the US Institute of Medicine [46] and 600 in
Japan [47]. Recommended nutritional intakes are 700 in
UK [48] and recommended dietary intakes 1300 in Aus-
tralian postmenopausal women [49]. Although scientific
evidence to support the daily dose of calcium is rather
weak, recent recommendations for postmenopausal women
(aged 50–70 years) include optimal dietary protein intake
of 1.0–1.2 g/kg body weight/d with at least 20–25 g of
high-quality protein at each main meal, with adequate
vitamin D intake at 800 IU/d to maintain serum 25-hy-
droxyvitamin D levels [50 nmol/L as well as calcium
intake of 1000 mg/d, alongside regular physical activity/
exercise 3–5 times/week combined with protein intake in
close proximity to exercise [50]. Several meta-analyses
support the role of calcium and vitamin D (mostly from
supplements) for the prevention of osteoporosis [51–53].
As a rich source of calcium, vitamin D and protein, dairy
products could be of help for reducing the risk of
osteoporosis.
The healthcare costs of osteoporosis are substantial. In a
review on the effects of dairy products in several medical
conditions, it was suggested that intake of the recom-
mended quantities of dairy products in the USA would
yield 5-year savings (limited to healthcare costs) of $209
billion [54]. Of this, $14 billion relate to savings on the
healthcare costs for osteoporosis (limited to treating frac-
tures) [54]. A recent study shows that, especially for
France, the Netherlands and Sweden, the societal burden of
hip fractures associated with low calcium intake is quite
substantial. Costs of fractures that might potentially be
reduced by improving dairy consumption have been cal-
culated at around €129 million in France and €34 million in
Sweden [55].
Protein malnutrition is frequent in the elderly and con-
tributes to the development of osteoporosis. Approximately
2 % (1–8 %) of the variance in BMD/BMC may be
explained by dietary protein intake, possibly via an
increase in serum IGF-I levels, with a reduction of proxi-
mal femur BMD loss and reduction of bone fracture risk
[56–59]. However, the role of dietary protein in osteo-
porosis remains controversial, as diets high in animal
protein (and sodium) have been linked to increased urinary
calcium excretion [60, 61], which could, in theory, lead to
bone loss and osteoporosis [62]. This ‘acid-ash hypothe-
sis’—first proposed 40 years ago—theorizes that high
animal protein intake results in metabolic acidosis and
increased urinary excretion of calcium. However, recent
human studies show that there is no relationship between
nutritional variations in urinary acid excretion and calcium
balance, bone metabolism and osteoporotic fracture risk
[63]. Furthermore, a systematic review and meta-analysis
concluded that a causal association between dietary acid
load and osteoporotic bone disease is not supported by
evidence [64]. The systematic review found weaknesses in
the acid-ash hypothesis, in terms of a lack of direct evi-
dence of osteoporosis progression (fragility fractures or
bone strength) from the intervention studies, a lack of
control for osteoporosis risk factors (such as weight loss,
family history of osteoporosis, baseline BMD and oestro-
gen status) in the supporting prospective cohort studies, no
biological mechanism functioning at physiological pH and
no evidence for an adverse role on osteoporosis of phos-
phate, milk and grain foods in the randomised studies [64].
Changes in urinary calcium are not reflected in calcium
balance [64], with high protein intakes increasing calcium
excretion—but without impairing calcium balance—and
possibly increasing intestinal calcium absorption [65].
Intakes of aromatic amino acids, which are prevalent in
dairy foods, increase IGF-I and stimulate the intestinal
absorption of calcium. A high dairy-protein diet has been
demonstrated to increase urinary calcium excretion but at
the same time improve calcium intake and attenuate bone
loss in overweight individuals on a weight loss and weight
maintenance diet [66]. A 2-year controlled trial has shown
beneficial effects on BMD of daily alkali supplements [67].
In summary, theories proposing harmful effects of dairies
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through the production of acid are not supported by
evidence.
Fracture Risk
Although, ideally, clinical outcome measures (fracture
incidence) would be used to assess the impact of dairy on
osteoporosis, in practice, research studies mostly utilise
surrogate outcomes, including BMD [68] and bone turn-
over markers. Controlled trials show a statistically signif-
icant positive association between dairy food intake and
BMC or BMD, and an inverse association with bone
turnover markers [26, 27].
In terms of actual fracture rates, meta-analyses support
some role of calcium and vitamin D (mostly from sup-
plements) for reducing the risk [51–53]. However, glob-
ally, the relationship between dietary calcium intakes and
fracture rates is not straightforward [69, 70]. Hip fracture
rates are in fact highest in countries with high calcium
intake and lowest where calcium intake is lower (the
opposite to what might be expected) [69]. Caucasian
women living in temperate climates have the highest rate
of hip fracture, while rates are somewhat lower in
Mediterranean and Asian women and lowest in African
women [69]. This incongruence may be due to the influ-
ence of vitamin D status (linked to latitude) and high levels
of bone-protective physical activity in poorer countries
with low dairy intakes [71] as well as differences in life
expectancy. Furthermore, there is a considerable physio-
logical capacity to adapt to low dietary calcium intakes
without compromising bone health [72].
Data on the relationship between dairy food intake and
fracture risk are currently limited. The available prospec-
tive studies are summarised in Table 3, comprising
observational data (albeit many with sizable populations)
but no RCTs. Overall, the studies to date have found
variable associations between dairy consumption and
fracture risk (Table 3).
A meta-analysis of prospective cohort studies in middle-
aged or older men and women demonstrated no overall
association between total milk intake and hip fracture risk
in women, with a reduction in relative risk of fracture of
9 % (relative risk 0.91, 95 % CI 0.81–1.01) per daily glass
of milk (containing approx. 300 mg calcium) among men,
which requires further validation [73]. However, the data
on women were strongly influenced by one study from
Sweden; the authors excluded this study from the analysis
on the basis of its disproportionate influence, whereupon
there was a marginally significant 5 % lower hip fracture
risk per glass of milk daily (pooled relative risk 0.95, 95 %
CI 0.90–1.00, P = 0.049) [73].
One of the largest populations with the longest follow-
up was the Nurses’ Health Study (Table 3). With a 12-year
follow-up, over 77,000 women aged 34–59 years assessed
dietary intake of calcium with a food-frequency question-
naire at intervals of 2–4 years, and there was no evidence
that higher intakes of milk or calcium from food sources
reduce fracture incidence, with relative risks of 1.45 (95 %
CI 0.87–2.43) for hip fracture and 1.05 (95 % CI
0.88–1.25) for forearm fracture for women drinking two or
more glasses of milk per day compared with women con-
suming one glass or less per week [74]. Furthermore,
women consuming greater amounts of calcium from dairy
foods had a modest but significantly increased risk of hip
fracture. However, as the authors point out, there was no
reason to suggest that dairy calcium itself was responsible
for this risk [74]. At 18 years of follow-up, there was
similarly no relationship between milk and fracture risk in
women [2].
The association between dairy product consumption and
hip fracture risk was also examined in a 12-year follow-up
of the Framingham Offspring cohort [75]. There was a
trend to a correlation between higher milk intake and
reduced hip fracture. Participants in the higher tertiles
(T2–3) of milk intake had a lower but non-significant risk
of hip fracture than those in the lowest tertile (T1) (T2 HR
0.78, 95 % CI 0.37–1.63; T3 HR 0.50, 95 % CI 0.22–1.13,
P trend = 0.09). Similarly, participants in the higher cat-
egories (C2–3) of yogurt intake showed a protective but
non-significant association with the risk of hip fracture as
compared to participants in the lowest category (C1) (C2
HR 0.39, 95 % CI 0.15–1.02, C3 HR 0.57, 95 % CI
0.19–1.68, P trend = 0.10). Participants in the highest
tertile (T3) of fluid dairy intake had a lower risk of hip
fracture than those in the lowest tertile (T1) (T3 vs T1,
P = 0.05) (T2 HR 0.92, 95 % CI 0.46–1.87, T3 HR 0.40,
95 % CI 0.17–0.99, P trend = 0.06) [75]. A protective
effect of milk was also identified in the Framingham
Original cohort [76]. When milk intake was analysed as
low versus medium/high intake, there was a trend to cor-
relation, with participants with medium ([1 and\7 serv-
ings/wk) or higher (C7 servings/wk) milk intake tending to
have lower hip fracture risk than those with low (B1
servings/wk) intake (high vs low intake: HR 0.58, 95 % CI
0.31–1.06, P = 0.078; medium vs low intake: HR 0.61,
95 % CI 0.36–1.08, P = 0.071; P trend: 0.178) [76]. Par-
ticipants with medium/high milk intake ([1 serving/wk)
had a 40 % lower risk of hip fracture, compared with those
with low milk intake (B1 serving/wk) (medium/high milk
intake: HR 0.60, 95 % CI 0.36–1.02, P = 0.061) [76].
However, both of these populations [75, 76] were relatively
small compared with the largest studies in Table 3.
A prospective study of 60,000 Swedish women aged
40–74 years who completed a self-administered food-
frequency questionnaire at baseline found no correlation
between dietary calcium or vitamin D intake for the
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primary prevention of osteoporotic fractures over
11 years of follow-up [77]. However, with 20.1 years of
prospective follow-up (61,000 Swedish women aged
39–74), fermented milk products (yogurt and other
soured milk products) and cheese consumption were
associated with a significant decrease in fracture inci-
dence and with lower mortality [78]. For each serving,
the rate of mortality and hip fractures was reduced by
10–15 % (P\ 0.001). However, in the same study, high
intakes of milk (3 or more glasses of milk; more than
600 ml/day) were associated with increased fracture rate,
and there was an association between higher cardiovas-
cular mortality and high milk intake at levels exceeding
the recommended doses (C3 glasses/d; C600 g/d), along
with a lesser effect of milk intake on cancer mortality
[78]. This level of consumption is much higher than the
mean milk intake of adults of most countries, and it is
worth noting that dietary questionnaires were performed
in 1987–1990 and 1997, when milk in Sweden was
fortified with high dose of vitamin A; high levels of
Table 3 Prospective data examining the link between dairy consumption and fracture risk
Study population Study findings Reference
Meta-analysis Meta-analysis of 6 prospective cohort studies (n = 39,563 men and women), with 152,000 person-
years of follow-up, found that low dairy intake (less than 1 glass of milk daily) was not associated
with a significantly increased risk of fracture (any fracture, osteoporotic fracture or hip fracture)
[139]
Meta-analysis Meta-analysis of 7 prospective cohort studies (195,102 women and 75,149 men, middle aged or
older) found that in women there was no association between total milk intake and hip fracture
risk, whereas men had a 9 % reduction in relative risk of fracture per daily glass of milk
[73]
Health Professionals Follow-up Study Prospective cohort study of 43,063 men (40–75 years of age at baseline) with 8-year follow-up
concluded that there was no relation between dairy calcium intake and forearm fracture. There
was a non-significant trend to reduction of hip fractures with the highest dairy calcium intakes
[140]
Study of Osteoporotic
Fractures (SOF Study)
Prospective cohort study of 9704 women (aged C 65 years) with mean 6.6-year follow-up
concluded that there was no association between milk intake and the risk of any of the fractures
studied. The exception was ankle fractures, which significantly decreased with increasing milk
intake
[141]
National Health Screening, Norway Prospective cohort study of 19,752 women and 20,035 men (middle aged) with mean 11.4-year
follow-up found an increased risk of hip fracture for people with a diet that was high in (non-dairy
animal) protein and low in milk intake (up to 1 glass of milk per day)
[142]
Japanese Adult Health Study Prospective cohort study of 4573 people (mean age 58.5 years) found that low milk intake was
marginally associated with an increased risk of hip fracture
[143]
Swedish Mammography Cohort Prospective cohort study of 60,689 women (aged 40–74 years at baseline) found that there was no
dose–response relationship between dietary calcium and risk of osteoporotic fracture
[77]
Swedish Mammography cohort
and Cohort of Swedish Men
Analysis of two prospective cohort studies, comprising 61,433 women and 45,339 men (aged
39–74 years at baseline), with mean follow-up of 20.1 years found that higher mortality (men and
women) and increased fracture (women) were associated with high milk intake. However, high
intake of cheese or fermented milk products was associated with lower mortality and fracture
rates in women
[78]
Framingham Offspring Prospective cohort of 3212 men and women (aged 26–85 at baseline) with 12 years of follow-up
found a weak protective trend of yogurt (but not other dairies) on risk of hip fracture
[75]
Framingham Original Cohort Prospective cohort study of 830 men and women with mean 11.6-year follow-up concluded that
greater intakes of milk and milk ? yogurt may lower risk for hip fracture in older adults
[76]
Nurses’ Health Study Prospective cohort study of 77,761 women (aged 34–59 years at baseline) with 12 years of follow-
up concluded that higher milk consumption did not protect against fracture (hip or forearm)
[74]
Nurses’ Health Study Prospective cohort study of 72,337 postmenopausal women with 18 years of follow-up found that
that milk did not reduce hip fracture risk
[2]
Nurses’ Health Study and Health
Professionals Follow-up Study
Prospective cohort study of 35,349 men (aged 40–75 years at baseline) and 61,578 women
(30–55 years of age at baseline) with 22-year follow-up found that milk consumption as a
teenager was not associated with hip fractures in adulthood
[144]
French Three-City Study Prospective cohort study of 1482 individuals (aged C67 years) with an 8-year follow-up found that
low intake of dairy products was associated with an increased risk of wrist fractures
[145]
European Prospective Investigation into
Cancer and nutrition study (EPIC)
Prospective study of 10,538 men and 18,584 women (aged C60 years), followed up for a median of
8 years, found that dairy consumption did not influence the risk of hip fracture
[146]
Spanish elderly cohort Prospective cohort study of 5201 women (aged C65 years) with 3-year follow-up found that dairy
calcium intake less than 250 mg/day was associated with the risk of non-spinal fracture
[147]
European Prospective Osteoporosis Study
(EPOS)
Prospective study of 3173 men and 3402 women (aged 50–79 years) with a mean 3.8-year follow-up
found that vertebral fracture was not associated with milk consumption
[148]
NHANES I Epidemiologic
Follow-Up Study cohort
Prospective cohort study of 4342 men and postmenopausal women (aged 50–74 at baseline), with up
to 16 years of follow-up, concluded that dietary calcium may reduce the risk of hip fracture in
late menopausal women
[149]
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vitamin A intake have been linked to an increased risk of
fracture [79].
It comes as no surprise that the findings of studies in this
area are variable (Table 3). The studies are observational in
nature and vary widely in terms of the age of the partici-
pants, background diets and length of follow-up. There is a
lack of RCTs investigating the relationship between dairy
food intake and fracture risk, which requires further study.
Incidence of fracture is the key clinical outcome that needs
to be measured in a longitudinal study; however, it is dif-
ficult to construct a dairy-free diet for the comparator group
that meets nutritional requirements for calcium and vitamin
D levels. Dietary studies are always difficult to control,
since increasing intake of one nutrient (or foodstuff) may
have an impact on other nutrients (or foodstuffs), affecting
the overall dietary composition and nutrient density. With
multiple nutrients known to affect bone health, it is par-
ticularly important that intake of each is considered.
Quantitating intake may also be particularly difficult and
variable between studies, due to differences in serving size
(for example ‘a glass of milk’, ‘a pot of yogurt’). Fur-
thermore, the study of such a long-term effect requires
either prohibitively expensive long-term prospective stud-
ies or the reliance on the memory of elderly subjects
concerning dairy product consumption for periods
extending as far back as childhood. Since a wide range of
genetic and lifestyle factors affect bone health, there is
great population variability and plenty of potentially con-
founding factors that require controls. Although epidemi-
ological studies potentially allow large sample numbers
and stratification for confounding factors, this design does
not allow any causal relationship to be established between
dairy consumption and fracture risk.
Other Potential Effects of Dairy Consumption
In this section, some of the perceived beliefs associated
with dairy consumption are briefly discussed, including
obesity, lactose intolerance, arthritis and cardiovascular
disease.
Dairy Products and Body Weight
Unfavourable body weight is a risk factor for many dis-
eases, including osteoporosis (under weight) and
osteoarthritis (over weight) [80], and obesity is a concern
of many patients and health professionals alike. Dairy
consumption has been studied extensively for its possible
roles in body weight regulation. However, the data are
conflicting. Four reviews or meta-analyses concluded that
neither calcium nor dairy intakes were reliably demon-
strated to aid in weight loss with or without caloric
restriction [81–84]. There is evidence to suggest that con-
sumption of dairy products reduces body fat but not nec-
essarily body weight, due to a preservation of lean body
mass [85–87]; and recent evidence from prospective cohort
studies suggests a protective effect of dairy consumption
on risk of overweight and obesity [88, 89]. Consumption of
dairy products has been associated with decreased preva-
lence of metabolic-related disorders [90], and even high-fat
dairy consumption within typical dietary patterns has been
inversely associated with risk of obesity.
The effect of dairy consumption on weight and body
composition has been investigated in two recent meta-
analyses [86, 87]. The first meta-analysis of 14 RCTs
involving 883 adults found that increasing dairy con-
sumption to recommended daily intake levels in adults who
do not follow any calorie-restricted diet had a small effect
on weight loss, but also a decrease in fat mass and waist
circumference and an increase in lean body mass [86].
When combined with energy restriction, dairy intake
showed a modest additional benefit on weight reduction
(-0.61 kg, 95 % CI -1.29 to 0.07, P = 0.08), greater
reduction in fat mass (-0.72 kg, 95 % CI -1.29 to -0.14,
P = 0.01), gain in lean mass (?0.58 kg, 95 % CI
0.18–0.99, P\ 0.01) and reduction in waist circumference
(-2.19 cm, 95 % CI -3.42 to -0.96, P\ 0.001) com-
pared with controls [86]. The second meta-analysis of 29
RCTs involving 2101 participants found that overall con-
sumption of dairy products did not result in a significant
reduction in weight. There was no significant difference in
body weight changes between the dairy intervention and
control groups (-0.14 kg, 95 % CI -0.66 to 0.38 kg);
however, a significant reduction that favoured dairy prod-
ucts in body fat was shown (-0.45 kg, 95 % CI -0.79 to
–0.11 kg) [87]. Dairy products significantly reduced body
weight in the short-term interventions (-0.47 kg, 95 % CI
-0.90 to -0.03 kg) but moderately increased weight gain
in long-term interventions (?0.66 kg, 95 % CI -0.14 to
1.46 kg). However, in the context of energy restriction, the
sub-group analysis demonstrated that consumption of dairy
products reduced body weight [87]. These two meta-anal-
yses suggest that dairy intake can aid weight and body fat
loss.
Other studies show the beneficial impact of specific
dairy products on weight management, particularly yogurt.
Changes in diet and lifestyle factors were evaluated
prospectively to determine their impact on long-term
weight gain among 22,557 men and 98,320 women inclu-
ded in health studies in the USA [85]. Over a 4-year period,
it was found that yogurt consumption was associated with a
significant reduction of weight gain [85]. In another study,
a cohort of 8516 Mediterranean men and women was
prospectively evaluated [91]. A high (C7 servings/wk)
consumption of total and whole-fat yogurt was associated
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with lower incidence of overweight/obesity in comparison
with low consumption (0–2 servings/wk) [91]. Together,
these studies suggest a benefit of including yogurt in the
diet in terms of weight management.
Mechanistic explanations for the possible association
between high dairy intake and lower body weight/body fat
mass found in observational studies include an effect of
increased dairy calcium intake on energy balance [92, 93].
Epidemiological data have shown that low calcium intake
is a risk factor for overweight and obesity. The clinical
implications of this relationship have been confirmed in
weight loss studies performed in low-calcium consumers in
whom calcium or dairy supplementation accentuated body
weight and fat loss [94–96]. Studies have demonstrated that
this effect may be explained by an increase in fat oxidation
and fat faecal loss as well as a facilitation of appetite
control. Indeed, dietary calcium may interfere with fat
absorption in the intestine by forming insoluble calcium
soaps with fatty acids and/or binding of bile acids, resulting
in a decrease in the digestible energy of the diet.
Dairy foods may also modulate body weight regulation
by calcium independent mechanisms. Dairy proteins sup-
press short-term food intake, increase satiety and stimulate
food intake regulatory mechanisms known to signal satia-
tion and satiety. Milk proteins may be another important
factor explaining the association between dairy consump-
tion and healthier body weights [97].
Lactose Intolerance
In some people, milk ingestion causes symptoms of
bloating, abdominal pain, flatulence and diarrhoea that can
be severe enough to prompt avoidance of all dairy foods.
The symptoms are caused by a deficiency of the enzyme
lactase (the lactose-digesting enzyme that breaks down
lactose into galactose and glucose for absorption) causing
undigested lactose to increase the osmolarity in the small
intestine (causing diarrhoea) and enter the colon where it is
fermented by the resident microflora, resulting in gas-
trointestinal symptoms. While self-diagnosis of lactase
deficiency is common, it is often incorrect and leads to
unnecessary elimination of dairy products and their nutri-
tional components. It may also result in osteoporosis, since
an increased incidence of lactose intolerance (along with a
significantly lower daily intake of calcium derived from
milk) has been found among women with ‘idiopathic’
osteoporosis [98, 99].
Some years ago, the only possible treatment for lactose
intolerance was the avoidance of lactose-containing foods,
including most dairy products. Indeed, many believe that
lactose intolerant individuals should not consume dairy
products. However, the avoidance of dairy products in
people with lactose intolerance is an area of controversy.
Most individuals with lactose intolerance can tolerate up to
12 g of lactose (250 ml of milk, representing 300 mg of
calcium and 30 % of recommended calcium intakes)
without suffering gastrointestinal symptoms, although
symptoms become more prominent at doses above 12 g
and are appreciable after 24 g of lactose [100, 101]. The
2010 Dietary Guidelines for Americans encourage daily
consumption of dairy foods and concur that it is important
for people with lactose intolerance to obtain the health and
nutritional benefits associated with dairy products, recom-
mending yogurt or cheese, or smaller portions, and lactose-
free varieties where necessary [13]. A National Institutes of
Health (NIH) Consensus and State-of-the-Science State-
ment confirms that even in persons with lactose
maldigestion, small amounts of milk, yogurt and hard
cheese, particularly if ingested with other foods and dis-
tributed throughout the day, and reduced-lactose food may
be effective management approaches, though the amount of
lactose subjects with lactose intolerance can take, is based
on low-quality evidence [102].
Yogurts (those with the two active bacterial cultures:
Lactobacillus delbrueckii subsp. bulgaricus and Strepto-
coccus thermophilus) and hard cheeses contain more pre-
digested lactose and may be more readily tolerated than
fluid milk [103, 104]. The bacterial lactase survives the
acidic conditions of the stomach, apparently being physi-
cally protected within the bacterial cells and facilitated by
the buffering capacity of yogurt. The increasing pH, as the
yogurt enters the small intestine, and a slower gastroin-
testinal transit time allow the bacterial lactase to be active,
digesting lactose from yogurt sufficiently to prevent
symptoms in lactose intolerant people [104]. Consequently,
the avoidance of all dairy products in lactose intolerant
patients is no longer recommended. Dietetic advice should
aim to ensure nutritional adequacy of the diet and to avoid
nutritional deficiencies—in particular a low calcium intake.
Since yogurt and hard cheese in particular are easily
digestible and well tolerated by people who find lactose
difficult to digest, they can be recommended as part of a
balanced diet to help lactose intolerant people take
advantage of the nutritional benefits of dairy products
[105].
In summary, to varying degrees depending on the
cultural history of dairy consumption, genetic lactase
persistence allows most of the population to continue to
consume some milk beyond the weaning period without
gastrointestinal adverse effects. For people who are lac-
tose intolerant, it is no longer necessary to avoid all dairy
foods, and in particular yogurt or hard cheese are well
tolerated and provide the nutritional benefits of dairy
products.
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Dairy Products and Joint Diseases
In people with chronic diseases, dietary manipulation is
common as they try to alleviate the symptoms. This is
particularly the case with painful conditions such as
osteoarthritis (OA) and rheumatoid arthritis (RA). How-
ever, scientific studies are required to control for all the
possible confounding factors and bias that might contribute
to any perceived dietary effect, and the available evidence
suggests that there is no reason why dairy consumption
should be avoided.
Best practice guidelines for OA emphasize self-man-
agement including weight control and exercise [106].
There is some evidence to suggest that a Western diet and
inactivity are pro-inflammatory and that low-grade
inflammation and oxidative stress underlying OA often
coexist with lifestyle-related risk factors and conditions
[107]. While dairy products have in the past been consid-
ered as pro-inflammatory [107], more recent data do not
support this hypothesis. In fact, full-fat dairy products and
dairy fats have either a neutral or inverse effect on levels of
circulating inflammatory biomarkers [108–112]. A meta-
analysis of nutritional interventional studies performed in
overweight or obese people found that dairy product con-
sumption does not exert adverse effects on inflammatory
biomarkers [113], and in an RCT among subjects with low-
grade systemic inflammation, consumption of a combina-
tion of low-fat and high-fat dairy products as part of a
healthy diet had no adverse effects on inflammation [114].
An association between frequent milk consumption and
reduced OA progression has been found in a recent study in
women, although no significant association was found in
men. Analysis of 2148 participants in the Osteoarthritis
Initiative identified a significant dose–response relationship
between baseline milk intake and OA progression in
women over a 4-year follow-up period [115]. Replication
of these novel findings in other prospective studies
demonstrating that increase in milk consumption leads to
delay in knee OA progression is needed.
For decades, patients have used different diets to try to
improve the symptoms of RA, and dietary manipulation is
still widely used today. A wide range of conflicting dietary
advice is available, yet a lack of scientific information
regarding its efficacy often leaves sufferers vulnerable. The
common dietary regimens used by people with RA include
vegetarian or vegan, Mediterranean, ‘elemental’ and
‘elimination’ diets (including dairy-free diets).
Diet, nutrition and weight loss have shown some pro-
mise in alleviating some of the RA disease burden [116].
Prospective studies suggest that dietary antioxidants may
be protective for RA, while high coffee consumption,
alcohol intake, smoking and obesity increase the risk of
developing RA [117]. Some studies suggest that certain
dietary elements including polyunsaturated fatty acids
(PUFAs), the Mediterranean diet and antioxidants have
anti-inflammatory effects and decrease RA disease activity
[118, 119].
However, the effects of dietary manipulation on RA are
still uncertain due to the studies being small, single trials
with moderate to high risk of bias [120, 121]. A Cochrane
review of 14 RCTs and 1 controlled clinical trial, with a
total of 837 patients, assessed the potential benefits and
harms associated with certain dietary regimens in RA
[121]. Due to heterogeneity of interventions and outcomes,
baseline imbalance and inadequate data reporting, no
overall effects were detected and the effects of vegan and
elimination diets were uncertain [121].
Dairy products contain a high content of saturated fatty
acids, and many of the shorter chain fatty acids found in
milk fat have beneficial health effects, with important
immune response functions. There is also evidence that the
proteins, fats and calcium in milk are beneficial in
inflammation [122]. Given the lack of understanding of the
nutritional requirements in RA, plus the variability in its
clinical course, it is difficult to produce specific dietary
recommendations for RA. Elimination diets, particularly
those with low intakes of dairy products, should be dis-
couraged [123], and suspected food intolerance tested
under strict clinical supervision [124]. Nutrient mega-
dosing is inadvisable, although dietary supplementation
with calcium, vitamin D, folic acid or multivitamins and
minerals may be recommended where necessary [124].
In summary, more research is needed, but based on the
available data, there appears to be no evidence why
patients with OA or RA should avoid dairy consumption,
considering the overall beneficial effect of dairy products
for health.
Dairy Consumption and Cardiovascular Disease
Globally, cardiovascular disease is a major cause of mor-
tality [125], and the influence of diet on known cardio-
vascular risk factors such as blood pressure, serum
cholesterol and body weight, is well established. Conse-
quently, the DASH (Dietary Approaches to Stop Hyper-
tension)-style diet—which incorporates moderate amounts
of low-fat dairy—protects against cardiovascular disease,
coronary heart disease, stroke and heart failure [126].
A review of the evidence concluded that most studies
report no association between dairy consumption and
increased risk of cardiovascular disease [127], with a meta-
analysis of RCT data finding no significant impact on
various cardio-metabolic risk factors following increased
dairy consumption (mean increase of 3.6 serves per day),
aside from a slight increase in body weight [128]. In fact,
dairy consumption may be protective against cardiovascular
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disease, with beneficial effects demonstrated on known
risk factors such as hypertension [129, 130] as well as
clinical outcomes [131–133]. For example, meta-analyses
of observational data have reported inverse associations
between overall cardiovascular disease and milk intake
(4 studies; RR 0.94 per 200 mL/d, 95 % CI 0.89–0.99)
[132] and dairy consumption (9 studies; RR 0.88, 95 % CI
0.81–0.96) [131]. There was also an inverse association
between dairy consumption and overall risk of stroke
(12 studies; RR 0.87, 95 % CI 0.77–0.99) [131], whilst
another meta-analysis found that total dairy (RR 0.88,
95 % CI 0.82–0.94), low-fat dairy (RR 0.91, 95 % CI 0.85
to 0.97), fermented milk (RR 0.80, 95 % CI 0.71–0.89) and
cheese (RR 0.94, 95 % CI 0.89–0.995)] were significantly
associated with reduced risk of stroke [133]. There was
no significant association between the risk of stroke and
intake of full-fat dairy, non-fermented milk, butter and
cream [133].
There is currently a lack of research into the effect of
full-fat dairy on cardiovascular disease [127], and the rel-
ative impact of high-fat dairy versus low-fat dairy is dif-
ficult to establish from the current evidence base. European
and American guidelines for preventing cardiovascular
disease recommend a reduction in total dietary saturated fat
[134, 135]. However, it is becoming clear that all saturated
fatty acids are not equal. For example, in a study using a
food-frequency questionnaire, a higher intake of saturated
fatty acids from meat increased incident cardiovascular
disease, whereas higher intake of saturated fatty acids from
dairy reduced the risk [136]. Research into understanding
the metabolic effects of individual fatty acids is still in the
early stages, but it would seem that structural characteris-
tics of the individual fatty acid and the food matrix within
which it is consumed are likely to have an effect. A meta-
analysis of prospective cohort studies reporting circulating
fatty acid composition revealed the variable effects of
individual saturated fatty acids, with a higher coronary risk
for palmitic (RR 1.15, 95 % CI 0.96–1.37) and stearic (RR
1.23, 95 % CI 0.93–1.61) acids, and a significantly lower
risk for margaric acid (RR 0.77, 95 % CI 0.63–0.93) [137].
Whilst the saturated fatty acids in whole milk and butter
increase low-density lipoprotein, they also increase high-
density lipoprotein, which leaves the ratio of total choles-
terol to high-density lipoprotein unchanged, or slightly
lowered [127].
A recent meta-analysis has concluded that calcium
supplements without co-administered vitamin D were
associated with an increased risk of myocardial infarction
[138]. However, there was no increased risk when calcium
was of dietary origin.
In summary, dairy consumption does not seem to sig-
nificantly increase the risk of cardiovascular disease,
particularly if low-fat, and more research is needed for full-
fat dairy products.
Discussion
Milk provides a package of essential nutrients that are
difficult to obtain in low-dairy or dairy-free diets. Dairy
products may represent a useful source of dietary calcium,
and for many people it is not possible to achieve recom-
mended daily calcium intakes with a dairy-free diet. The
link between dairy product intakes and fracture risk
reduction (Table 3) is still challenged. To demonstrate an
effect on fracture risk would require further large and well-
designed rigorously controlled studies.
Nevertheless, it can be inferred from the above-men-
tioned data that regular consumption of dairy throughout
life is likely to be beneficial for skeletal health. Besides
bone health, more controversial are the beliefs around
including dairy as part of a healthy balanced diet. Among
some members of the public and health professionals,
doubts persist that dairy may be detrimental to health. In
some cases, these are simply beliefs or a consequence of
misinformation, but in other cases plausible mechanisms
exist, casting doubt in even the most scientific mind. This
review has discussed some of the most common concerns
over the inclusion of dairy in the diet, including those of
people with weight management issues or lactose intoler-
ance, with OA or RA or with cardiovascular disease. The
overall message is that the benefits outweigh any (in many
cases perceived, not real) harm.
Lactose intolerance can prompt an avoidance of all
dairies, but this is not necessary in most people. In par-
ticular, yogurt and hard cheese are well tolerated and
provide the nutritional benefits of dairy products.
The effect of dairy consumption on body weight and
composition has been investigated extensively, with con-
flicting results. There may be a weak association between
dairy consumption and a possible small weight reduction,
with decreases in fat mass and waist circumference and
increases in lean body mass.
The evidence for any role of dairy foods in inflammation
is conflicting and limited to small observational or clinical
trials. Although dairy foods have in the past been consid-
ered pro-inflammatory [107], studies of dairy consumption
demonstrate that full-fat dairy products and dairy fats in
fact have either a neutral or inverse effect on levels of
circulating inflammatory biomarkers [108–114]. Recently,
a single observational study suggested a reduction in OA
progression associated with frequent milk consumption
among women [115]. Dietary guidelines are difficult to
define for RA, but patients should be discouraged from
eliminating dairy [123] in their attempts to control their
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symptoms, and a balanced nutritionally complete diet
should be advised.
Most studies report no association between dairy con-
sumption and increased risk of cardiovascular disease
[127], and in fact low-fat dairy may be protective [131–
133]. More research is needed in this respect for full-fat
dairy products.
In conclusion, dairy products may represent a valuable
dietary source of calcium due to their high calcium and
nutrient contents, high absorptive rate, availability and
relatively low cost. Numerous national nutritional recom-
mendations are for 3 servings of dairy products per day (for
example, 1 glass of milk, 1 portion of cheese, 1 yogurt), an
amount that provides the recommended daily intake of
calcium. By understanding fully the accumulating scientific
data in this area, health professionals can play an important
role in dispelling these beliefs surrounding dairy products.
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